Delaware
|
1-35040
|
27-4576073
|
(State or other jurisdiction of incorporation or organization)
|
(Commission file number)
|
(I.R.S. employer identification no.)
|
280 Park Avenue
6th Floor East
(Address of principal executive offices)
|
10017
(Zip code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
|||
Common Stock, par value $0.001 per share
|
MCC
|
New York Stock Exchange (NYSE)
|
|||
6.125% Notes due 2023
|
MCV
|
New York Stock Exchange (NYSE)
|
Emerging growth company | ☐ |
Item 5.03
|
Amendments to Articles of Incorporation or Bylaws.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) |
Exhibits
|
Exhibit No.
|
Description
|
3.1
|
|
3.2
|
DATE: December 28, 2020
|
MEDLEY CAPITAL CORPORATION
|
/s/ David Lorber
|
Name: David Lorber
|
|
Title: Director and Authorized Signatory
|
Medley Capital Corporation
|
|||
By:
|
/s/ David Lorber |
Title:
|
Director | |
Name:
|
David Lorber |